63
Participants
Start Date
August 29, 2006
Primary Completion Date
December 31, 2016
Study Completion Date
December 10, 2024
Laboratory Biomarker Analysis
Optional correlative studies
Pharmacogenomic Study
Optional correlative studies
Sunitinib
Given PO
Sunitinib Malate
Given PO
University of Maryland/Greenebaum Cancer Center, Baltimore
Northern Indiana Cancer Research Consortium, South Bend
Fort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne
University of Michigan Comprehensive Cancer Center, Ann Arbor
Oncology Care Associates PLLC, Saint Joseph
Medical College of Wisconsin, Milwaukee
Loyola University Medical Center, Maywood
NorthShore University HealthSystem-Evanston Hospital, Evanston
Ingalls Memorial Hospital, Harvey
Duly Health and Care Joliet, Joliet
University of Chicago Comprehensive Cancer Center, Chicago
Illinois CancerCare-Peoria, Peoria
Decatur Memorial Hospital, Decatur
Central Illinois Hematology Oncology Center, Springfield
Southern Illinois University School of Medicine, Springfield
Mercy Hospital Saint Louis, St Louis
M D Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH